Literature DB >> 17130623

The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.

Ronald M Davis1, Clifford E Douglas, John K Beasley.   

Abstract

Research on previously secret tobacco industry documents has grown substantially during the past decade, since these documents first became available as the result of private and governmental litigation and investigations by the US Congress and the US Food and Drug Administration. Complementary research on tobacco litigation testimony is now being conducted through the Tobacco Deposition and Trial Testimony Archive (DATTA) project. We obtained transcripts of depositions and trial testimony, deposition and trial exhibits, expert reports, and other litigation documents from law firms, court reporter firms, individual lawyers and witnesses, tobacco company websites, and other sources. As of 3 March 2006, the publicly available collection of DATTA (http://tobaccodocuments.org/datta) contained 4850 transcripts of depositions and trial testimony, including a total of about 820,000 transcript pages. Transcripts covered testimony from 1957 to 2005 (85% were for testimony from 1990 to 2005) given by more than 1500 witnesses in a total of 232 lawsuits. Twelve research teams were established to study the transcripts, with each team covering a particular topic (for example, the health consequences of tobacco use, addiction and pharmacology, tobacco advertising and promotion, tobacco-product design and manufacture, economic impact of tobacco use, youth initiation of tobacco use, and public understanding of the risks of tobacco use and exposure to second-hand smoke). The teams used qualitative research methods to analyse the documents, and their initial findings are published throughout this journal supplement.

Entities:  

Mesh:

Year:  2006        PMID: 17130623      PMCID: PMC2563580          DOI: 10.1136/tc.2006.016667

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  3 in total

1.  Why tobacco litigation?

Authors:  R Daynard
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

2.  Tobacco litigation as cancer prevention: dealing with the devil.

Authors:  G J Annas
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

3.  Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.

Authors:  Clifford E Douglas; Ronald M Davis; John K Beasley
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

  3 in total
  11 in total

Review 1.  The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.

Authors:  Marvin E Goldberg; Ronald M Davis; Anne Marie O'Keefe
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

2.  Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.

Authors:  Sharon Milberger; Ronald M Davis; Clifford E Douglas; John K Beasley; David Burns; Thomas Houston; Donald Shopland
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

Review 3.  Economics on trial: the use and abuse of economic methods in third party tobacco litigation.

Authors:  Wendy Max; Theo Tsoukalas
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

4.  How the health belief model helps the tobacco industry: individuals, choice, and "information".

Authors:  Edith D Balbach; Elizabeth A Smith; Ruth E Malone
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

Review 5.  Tobacco industry litigation position on addiction: continued dependence on past views.

Authors:  Jack E Henningfield; Christine A Rose; Mitch Zeller
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

Review 6.  Potential reduced exposure products (PREPs) in industry trial testimony.

Authors:  Geoffrey Ferris Wayne
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

Review 7.  Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses.

Authors:  John A Francis; Amy K Shea; Jonathan M Samet
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

8.  Testimony by otolaryngologists in defense of tobacco companies 2009-2014.

Authors:  Robert K Jackler
Journal:  Laryngoscope       Date:  2015-07-17       Impact factor: 3.325

9.  Talc, Asbestos, and Epidemiology: Corporate Influence and Scientific Incognizance.

Authors:  Triet H Tran; Joan E Steffen; Kate M Clancy; Tess Bird; David S Egilman
Journal:  Epidemiology       Date:  2019-11       Impact factor: 4.822

10.  British American Tobacco ghost-wrote reports on tobacco advertising bans by the International Advertising Association and J J Boddewyn.

Authors:  R M Davis
Journal:  Tob Control       Date:  2008-03-13       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.